Skip to content

A study to compare the effect of Nasya with or without oral medication in the management of Migraine

A comparative study to evaluate the efficacy of Bala Guduchayadi Tail Nasya with or without oral administration of Khandasama Churana in the management of Ardhavbhedaka w.s.r to Migraine - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066843
Enrollment
60
Registered
2024-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Sponsors

Dayanand Ayurvedic College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient who are willing for study. Patients who fulfills the classical symtoms of Ardhaavbhedhaka (Migraine) and fulfilling ICHS criteria Patients of age more than 16 years and not more than 60 years irrespective of sex, religion & occupations will be selected for the study. ? Patients fit for Nasya

Exclusion criteria

Exclusion criteria: Patients not willing for study. ? Patients suffering from any other forms of headache apart from Ardhaavbhedhaka. ? Headaches secondary to medical conditions like Meningitis, Tumor, encephalitis, Spondylosis or any other intracranial lesions and Refractive errors etc. ? Patients with complications of Migraine e.g status migrainosus, migraine aura triggered seizure, probable migraine etc

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Bala Guduchayadi Tail Nasya in the management of Ardhavbhedaka w.s.r. to Migraine ? To evaluate the efficacy of Bala Guduchayadi Tail Nasya with oral administration of Khandasama Churna in the management of Ardhavbhedaka ? To compare the efficacy of Nasya Karma with or without oral administration of Khandasama Churna in the management of ArdhavbhedakaTimepoint: 28 days

Secondary

MeasureTime frame
To provide economic, easily manageable, permanent and adverse affect free treatment for migraineTimepoint: 28 days

Countries

India

Contacts

Public ContactDr Megha Pathak

Dayanand Ayurvedic college

drparv1@gmail.com7589303536

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026